Back to search
FDAFDA · Food and drugs·Recall number D-0651-2016

Nystatin, USP Powder for Rx compounding, 50 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0405-05, UPC 305740404058.

Published February 10, 2016 · Recall initiated: January 18, 2016

Summary

FDA records drug Class II recall D-0651-2016, published February 10, 2016 and initiated January 18, 2016. Recalling firm: Perrigo Company PLC; Status: Terminated; Reported quantity: 948 units; Lot: Lot #: 2015050194, Exp 2/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: label error on declared strength.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Perrigo Company PLC
Distributor
Nationwide
UPC
305740404058
Lot
Lot #: 2015050194, Exp 2/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nystatin, USP Powder for Rx compounding, 50 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0405-05, UPC 305740404058. recalled?

Yes. FDA published recall D-0651-2016 on February 10, 2016. Reported hazard: Labeling: label error on declared strength.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 305740404058.